Non-toxic cadmium concentrations induce vascular inflammation and promote atherosclerosis

Circulation Journal

Volumn 75, Issue 10, 2011, Pages 2491-2495

  Knoflach, Michael ^a   Messner, Barbera ^a   Shen, Ying H ^b   Frotschnig, Sandra ^a   Liu, Guanghui ^b   Pfaller, Kristian ^a   Wang, Xingli ^b   Matosevic, Benjamin ^c   Willeit, Johann ^a   Kiechl, Stefan ^a   Laufer, Günther ^c   Bernhard, David ^c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Cadmium; Inflammation; Mouse; Plaques

Indexed keywords

CADMIUM; CD3 ANTIGEN; CD68 ANTIGEN; HEAT SHOCK PROTEIN 60; INTERLEUKIN 2 RECEPTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; CELL ACTIVITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; VASCULITIS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CADMIUM; CHAPERONIN 60; ENDOTHELIUM, VASCULAR; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1; VASCULITIS;

EID: 80053080021     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0196     Document Type: Article

References (24)

1. Messner B, Knoflach M, Seubert A, Ritsch A, Pfaller K, Henderson B, et al. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol 2009; 29: 1392-1398.
2. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 2004; 109: 3196-3201.
3. Peters JL, Perlstein TS, Perry MJ, McNeely E, Weuve J. Cadmium exposure in association with history of stroke and heart failure. Environ Res 2010; 110: 199-206.
4. Messner B, Bernhard D. Cadmium and cardiovascular diseases: Cell biology, pathophysiology, and epidemiological relevance. Biometals 2010; 23: 811-822.
5. Szuster-Ciesielska A, Lokaj I, Kandefer-Szerszen M. The influence of cadmium and zinc ions on the interferon and tumor necrosis factor production in bovine aorta endothelial cells. Toxicology 2000; 145: 135-145.
6. Park SL, Kim YM, Ahn JH, Lee SH, Baik EJ, Moon CH, et al. Cadmium stimulates the expression of vascular cell adhesion molecule-1 (VCAM-1) via p38 mitogen-activated protein kinase (MAPK) and JNK activation in cerebrovascular endothelial cells. J Pharmacol Sci 2009; 110: 405-409.
7. Mlynek V, Skoczynska A. The proinflammatory activity of cadmium. Postepy Hig Med Dosw (Online) 2005; 59: 1-8 (in Polish).
8. Agrawal A, Bhattacharya S. Appearance of C-reactive protein (CRP) in serum and liver cytosol of cadmium-treated rats. Indian J Exp Biol 1989; 27: 1024-1027.
9. Prozialeck WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Life Sci 2006; 79: 1493-1506.
10. Prozialeck WC, Edwards JR, Nebert DW, Woods JM, Barchowsky A, Atchison WD. The vascular system as a target of metal toxicity. Toxicol Sci 2008; 102: 207-218.
11. Thijssen S, Maringwa J, Faes C, Lambrichts I, Van Kerkhove E. Chronic exposure of mice to environmentally relevant, low doses of cadmium leads to early renal damage, not predicted by blood or urine cadmium levels. Toxicology 2007; 229: 145-156.
12. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994; 89: 2462-2478.
13. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92: 1355-1374.
14. Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 2004; 22: 362-403.
15. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: Transition from theory to practice. Circ J 2010; 74: 213-220.
16. Millonig G, Malcom GT, Wick G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 2002; 160: 441-448.
17. Xu Q, Kleindienst R, Waitz W, Dietrich H, Wick G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest 1993; 91: 2693-2702.
18. Kimura S, Sawada T. Understanding the essential role of monocytes in atherosclerosis. Circ J 2010; 74: 1292-1293.
19. Knoflach M, Kiechl S, Mayrl B, Kind M, Gaston JS, van der Zee R, et al. T-cell reactivity against HSP60 relates to early but not advanced atherosclerosis. Atherosclerosis 2007; 195: 333-338.
20. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-2503.
21. Back M, Ketelhuth DF, Agewall S. Matrix metalloproteinases in atherothrombosis. Prog Cardiovasc Dis 2010; 52: 410-428.
22. Park JP, Lee BK, Shim JM, Kim SH, Lee CW, Kang DH, et al. Relationship between multiple plasma biomarkers and vulnerable plaque determined by virtual histology intravascular ultrasound. Circ J 2010; 74: 332-336.
23. Ross R, Glomset JA. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med 1976; 295: 420-425.
24. Ross R. The pathogenesis of atherosclerosis: An update. N Engl J Med 1986; 314: 488-500.